Large Cap Biopharmaceuticals Performance…Update-3 #ASCO24 gains are ahead
UPDATE 3: Large cap biopharmas were strong on Friday in anticipation of #ASCO24 data. Company news to watch from data below:AZN, BMY, GILD, LLY, MRK, PFE,REGN and also ADPT, MRUS, NVS. REPL.. See updates all next week. Update-2 MAY 31,,,Biopharma stocks took a dip midweek during FED speak then...
SMID Life Science Trades that Picked Up MOMENTUM…Update-4…nothing
Update-4 5/23/24...XBI down 3% to $89 handle, rates up =risk off, But S&P hold 5200. NVDA rules nothing else in broad sell-off. Update-3 5/22...XBI is holding the $92 level and several SMID stocks show gains:ADPT, CRNX,CRSP, PACB, TXG. NTRA near 52 wet high of $110. NVAX up 13% to $16.84...
Healthcare and Biotech Investing 101: What you need to know.
Healthcare and Biotech Investing 101: What you need to know. What is your current allocation for healthcare stocks? Large cap stocks that pay dividends are the best positioned for growth plus value. Start with an ETF plus one Fund. If you have been reading our artlcles you already know some of...
SMID Life Science Trades: Trading Window is Open…Update-5
Update-5 SMIDS are running today. Added NVAX to list. ADPT RXRX XBI are movers. UPDATE-4...AT close...XBI tried to rally back to $90 but closed at $88+. XBI drives SMID biotechs and as you can see it's a red screen day if you are tracking our spec trading list below. BUT the bull market is...
Healthcare Markets Weekly Summary: SMID Biotechs Lagging…Update-3…SMID Biotech Rally Underway
MAY 1..3:00P EDT...XBI up over 5 %, Spec biotech rally! Details later. April 30 ...Sell off at close -FED jitters plus yieldsup not a good combo. Labor costs rise,US consumer sentiment drops ,worst month since 9/22. NAZ and Russell down over 2%, S&P down 1.57%. IS it time for Healthcare...